DMAC
DiaMedica Therapeutics Inc. · Healthcare · Market cap $468.6M
Insider Buying
$7.6M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Latest filing
Aug 12, 2026
STAHLBERG JAN
DiaMedica Therapeutics Inc. (DMAC) has 6 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 12, 2026.
Inside the rolling window, 1 insider at DiaMedica Therapeutics Inc. reported 7 open-market purchases totaling $7.6M and no open-market sales. The most active filer is 10% Owner STAHLBERG JAN with 7 filings. The most recent open-market filing is a purchase of 187,393 shares by 10% Owner STAHLBERG JAN, dated Nov 17, 2025, worth $1.2M.
- Industry:Biotechnology
- CEO:Dietrich John Pauls
- Employees:35
- HQ:Minneapolis, MN, US
- IPO:2012-08-03
| Source | |||||||
|---|---|---|---|---|---|---|---|
STAHLBERG JANFirst filing | 10% Owner | Purchase | 187,393 | $1.2M | Dec 8 | -0.8% | SEC ↗ |
STAHLBERG JANFirst filing | 10% Owner | Purchase | 182,882 | $1.2M | Dec 8 | -0.8% | SEC ↗ |
STAHLBERG JANFirst filing | 10% Owner | Purchase | 240,352 | $1.7M | Dec 8 | -0.8% | SEC ↗ |
STAHLBERG JANFirst filing | 10% Owner | Purchase | 128,426 | $951K | Dec 8 | -0.8% | SEC ↗ |
STAHLBERG JANFirst filing | 10% Owner | Purchase | 208,872 | $1.5M | Dec 8 | -0.8% | SEC ↗ |
STAHLBERG JANFirst filing | 10% Owner | Purchase | 40,253 | $318K | Dec 8 | -0.8% | SEC ↗ |
STAHLBERG JANFirst filing | 10% Owner | Purchase | 73,099 | $627K | Dec 8 | -0.8% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does DMAC have?
DiaMedica Therapeutics Inc. (DMAC) has 6 SEC Form 4 filings (12 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Aug 12, 2026.
When was the most recent SEC Form 4 filing for DMAC?
The most recent Form 4 filing for DMAC on Tracefour is dated Aug 12, 2026.
Who is the most active insider at DMAC?
The most active SEC Form 4 filer at DMAC in the rolling window is 10% Owner STAHLBERG JAN, with 7 filings.
What is the total insider buy and sell value at DMAC in the current window?
Inside the rolling window, insiders at DMAC bought $7.6M and sold $0 based on SEC Form 4 filings.
Can I get alerts for DMAC insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at DiaMedica Therapeutics Inc. (DMAC). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
DiaMedica Therapeutics Inc. is in the Healthcare sector.